يعرض 1 - 20 نتائج من 58 نتيجة بحث عن '"G. Diebold"', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
  4. 4

    المساهمون: Matériaux, ingénierie et science [Villeurbanne] (MATEIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Journal of Clinical Pharmacy and Therapeutics
    Journal of Clinical Pharmacy and Therapeutics, 2016, 41 (1), pp.47-53. ⟨10.1111/jcpt.12346⟩

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    المساهمون: Matériaux, ingénierie et science [Villeurbanne] ( MATEIS ), Université Claude Bernard Lyon 1 ( UCBL ), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique ( CNRS ) -Institut National des Sciences Appliquées de Lyon ( INSA Lyon ), Université de Lyon-Institut National des Sciences Appliquées ( INSA ) -Institut National des Sciences Appliquées ( INSA ), Matériaux, ingénierie et science [Villeurbanne] (MATEIS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Journal of Clinical Pharmacy and Therapeutics
    Journal of Clinical Pharmacy and Therapeutics, 2014, 39 (6), pp.642-648. 〈10.1111/jcpt.12199〉
    Journal of Clinical Pharmacy and Therapeutics, 2014, 39 (6), pp.642-648. ⟨10.1111/jcpt.12199⟩

    مصطلحات موضوعية: Male, medicine.medical_treatment, retrospective study, lomustine, Hospitals, University, 0302 clinical medicine, analogs and derivatives, Pharmacology (medical), cancer survival, comparative study, adult, health care cost, cohort analysis, 3. Good health, clinical practice, Survival Rate, Local, 030220 oncology & carcinogenesis, Quality-Adjusted Life Years, medicine.medical_specialty, Bevacizumab, drug cost, Antineoplastic Agents, bevacizumab, university hospital, Article, 03 medical and health sciences, cancer combination chemotherapy, Humans, human, procedures, Aged, Retrospective Studies, Pharmacology, procarbazine, medicine.disease, major clinical study, tumor recurrence, Radiation therapy, Regimen, Neoplasm Recurrence, monoclonal antibody, Glioblastoma, 030217 neurology & neurosurgery, cancer patient, Time Factors, Cost effectiveness, Total cost, nitrosourea, Cost-Benefit Analysis, cost of illness, drug implant, temozolomide, [SPI.MAT]Engineering Sciences [physics]/Materials, Cohort Studies, cost benefit analysis, quality adjusted life year, Monoclonal, Hospital Costs, multimodality cancer therapy, Humanized, irinotecan, antineoplastic agent, time, cancer adjuvant therapy, Cost-effectiveness analysis, Chemoradiotherapy, Health Care Costs, fotemustine, Middle Aged, Hospitals, Dacarbazine, Treatment Outcome, Female, France, hospital cost, medicine.drug, overall survival, [ SPI.MAT ] Engineering Sciences [physics]/Materials, Antibodies, Monoclonal, Humanized, vincristine, Antibodies, Drug Costs, Internal medicine, medicine, cancer radiotherapy, follow up, controlled study, University, Temozolomide, carmustine, business.industry, cost effectiveness analysis, economics, Surgery, cancer recurrence, pathology, Neoplasm Recurrence, Local, business, hospital care, Follow-Up Studies

  11. 11
    Academic Journal

    المساهمون: T. Armstrong, K. o. Barish, S. Batsouli, S. Bennett, M. p. Bertaina, A. Chikanian, S. q. Coe, T. Cormier, R. r. Davie, G. DeCataldo, P. Dee, G. Diebold, C. Dover, P. Fachini, B. Fadem, L. Finch, N. George, N. Giglietto, S. Greene, P. s. Harida, J. Hill, A. Hirsch, R. Hoversten, H. Huang, H. Jaradat, B. m. Kim, B. t. Kumar, T. Laini, J. Lajoie, R. Lewi, Q. Li, B. u. Libby, R. Majka, T. Miller, M. Munhoz, J. Nagle, I. Ple, J. v. Pope, N. Porile, C. Pruneau, M. Rabin, J. w. Reid, A. x. Rimai, A. Rose, F. y. Rotondo, J. Sandwei, R. Scharenberg, A. Slaughter, G. Smith, P. Spinelli, M. z. Tincknell, W. Toothacker, G. h. Van, W. Wilson, F. Wohn, E. a. Wolin, Z. Xu, K. Zhao

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000168640900038; volume:63; firstpage:549031; lastpage:5490318; numberofpages:8; journal:PHYSICAL REVIEW. C, NUCLEAR PHYSICS; http://hdl.handle.net/2318/126190; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-14344281215; http://www.scopus.com/inward/record.url?eid=2-s2.0-14344281215&partnerID=40&md5=7684de7d4beac78a3fe2a77b384dcec0

  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    المساهمون: Institut de Recherches Subatomiques (IReS), Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3)-Cancéropôle du Grand Est-Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS)

    المصدر: Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
    Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, Elsevier, 1992, 320, pp.300-304
    Scopus-Elsevier